Detalhe da pesquisa
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
2.
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature
; 558(7709): 307-312, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849141
3.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
4.
Life satisfaction in cardiac arrest survivors: A nationwide Swedish registry study.
Resusc Plus
; 15: 100451, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662640
5.
TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells.
Sci Adv
; 9(29): eadh2605, 2023 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467321
6.
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL.
Cancer Res Commun
; 2(9): 1089-1103, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922932
7.
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL.
Sci Adv
; 8(23): eabj2820, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675405
8.
Next-generation CAR T cells to overcome current drawbacks.
Int J Hematol
; 114(5): 532-543, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594314
9.
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006631
10.
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancer.
Clin Exp Med
; 20(4): 469-480, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333215
11.
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.
Cancer Immunol Res
; 6(9): 1100-1109, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030295
12.
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 24(5): 563-571, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713085
13.
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 27(3): 561, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547459